Insight into the pharmacokinetic behavior of tanshinone IIA in the treatment of Crohn’s disease: comparative data for tanshinone IIA and its two glucuronidated metabolites in normal and recurrent colitis models after oral administration

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  2017-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/00498254.2016.1160158PMID 27045386
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene expression

  2019cited by this paper
• Antisense Approach to Inflammatory Bowel Disease: Prospects and Challenges

  2015cited by this paper
• Establishment of an interleukin-1β-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis

  2015cited by this paper
• Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.

  2015cited by this paper
• Ginsenoside Rg3 bile salt-phosphatidylcholine-based mixed micelles: design, characterization, and evaluation.

  2015cited by this paper
• Chronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-κb pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mice

  2015cited by this paper
• The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease

  2015cited by this paper
• Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles.

  2015cited by this paper
• Acute murine colitis reduces colonic 5-aminosalicylic acid metabolism by regulation of N-acetyltransferase-2.

  2014cited by this paper
• Salvia miltiorrhiza increases the expression of transcription factor Foxp3 in experimental murine colitis.

  2014cited by this paper
• Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice.

  2014cited by this paper
• PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis

  2014influential reference
• UDP-Glucuronosyltransferase 1A Compromises Intracellular Accumulation and Anti-Cancer Effect of Tanshinone IIA in Human Colon Cancer Cells

  2013cited by this paper
• Disturbance of hepatic and intestinal UDP-glucuronosyltransferase in rats with trinitrobenzene sulfonic acid-induced colitis.

  2013cited by this paper
• Salvia miltiorrhiza (dan shen) significantly ameliorates colon inflammation in dextran sulfate sodium induced colitis.

  2013cited by this paper
• Metabolic profile, enzyme kinetics, and reaction phenotyping of β-lapachone metabolism in human liver and intestine in vitro.

  2012cited by this paper
• Temporal Colonic Gene Expression Profiling in the Recurrent Colitis Model Identifies Early and Chronic Inflammatory Processes

  2012influential reference
• Gene Expression Profiling Identifies Mechanisms of Protection to Recurrent Trinitrobenzene Sulfonic Acid Colitis Mediated by Probiotics

  2012cited by this paper
• Localized colonic stem cell transplantation enhances tissue regeneration in murine colitis

  2012cited by this paper
• Anti-nociceptive effects of Tanshinone IIA (TIIA) in a rat model of complete Freund's adjuvant (CFA)-induced inflammatory pain.

  2012cited by this paper
• Th17-related cytokines: new players in the control of chronic intestinal inflammation

  2011cited by this paper
• Regioselective Glucuronidation of Tanshinone IIa after Quinone Reduction: Identification of Human UDP-Glucuronosyltransferases, Species Differences, and Interaction Potential

  2010influential reference
• 20(S)-Ginsenoside Rh2 Noncompetitively Inhibits P-Glycoprotein In Vitro and In Vivo: A Case for Herb-Drug Interactions

  2010cited by this paper
• he anti-inflammatory activities of Tanshinone IIA , an active component of TCM , re mediated by estrogen receptor activation and inhibition of iNOS uan -

  2009cited by this paper
• Treatment of inflammatory bowel disease: a review of medical therapy.

  2008cited by this paper
• Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases

  2008influential reference
• Tanshinone IIA Ameliorates Trinitrobenzene Sulfonic Acid (TNBS)-Induced Murine Colitis

  2008influential reference
• Possibility of enterohepatic recycling of ketoprofen in dogs.

  2008cited by this paper
• Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation.

  2007influential reference
• Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.

  2007cited by this paper
• In IBD eight can come before four.

  2006cited by this paper
• Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS).

  2006influential reference
• Pharmacokinetics, Absorption and Tissue Distribution of Tanshinone IIA Solid Dispersion

  2006influential reference
• A Mechanistic Study of the Intestinal Absorption of Cryptotanshinone, the Major Active Constituent of Salvia miltiorrhiza

  2006cited by this paper
• Identification of tanshinone IIA metabolites in rat liver microsomes by liquid chromatography-tandem mass spectrometry.

  2006influential reference
• Simultaneous determination of tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-electrospray ionisation-mass spectrometry.

  2005influential reference
• IL-1-beta

  2004cited by this paper
• IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation.

  2001cited by this paper
• IL-1β-converting enzyme (caspase-1) in intestinal inflammation

  2001cited by this paper
• Bile Acids: The Good, the Bad, and the Ugly.

  1999cited by this paper
• Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines

  1998cited by this paper
• Enantioselectivity of the enterohepatic recycling of carprofen in the dog.

  1998cited by this paper
• Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat.

  1997cited by this paper
• Antibodies to interleukin 12 abrogate established experimental colitis in mice

  1995cited by this paper
• Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats.

  1986cited by this paper
• Influence of bile on the gastrointestinal absorption of phenytoin in rats.

  1985cited by this paper

• Traditional Chinese medicine of Salvia miltiorrhiza Bunge: a review of phytochemistry, pharmacology and pharmacokinetics

  2021cites this paper
• Pharmacological properties of tanshinones, the natural products from Salvia miltiorrhiza.

  2020cites this paper
• Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis

  2019cites this paper
• Comparative pharmacokinetics of (S)-MP3950, a novel 5-HT4 receptor agonist, in normal and atropine-induced gastrointestinal motility disorders rats

  2018cites this paper
• Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules

  2018cites this paper